SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 12, 2004
Specialty Laboratories, Inc.
(Exact name of registrant as specified in its charter)
California
(State or other jurisdiction of incorporation)
|
001-16217 |
|
95-2961036 |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
|
|
|
|
2211 Michigan Avenue Santa Monica, California |
|
90404 |
|
Address of principal executive offices) |
|
(Zip Code) |
|
|
|
|
|
Registrant’s telephone number, including area code: (310) 828-6543 |
||
|
|
|
|
|
Not applicable |
||
|
(Former name or former address, if changed since last report) |
||
Item 5. Other Events and Regulation FD Disclosure.
On April 12, 2004, Specialty Laboratories, Inc., (the “Registrant”) announced the appointment of Kevin R. Sayer as Executive Vice President and Chief Financial Officer effective April 12, 2004.
A copy of the press release issued by the Registrant on April 12, 2004 concerning the foregoing matter is filed herewith as Exhibit 99.1 and is incorporated herein by reference.
|
Item 7. |
|
Financial Statements and Exhibits |
|
|
|
|
|
|
|
(c) |
|
Exhibits |
The following document is filed as an exhibit to this report: |
|
|
|
|
|
|
|
|
99.1 |
Press Release dated April 12, 2004. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, Specialty Laboratories, Inc. has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized, in the City of Santa Monica, State of California, on April 12, 2004.
|
|
SPECIALTY LABORATORIES, INC. |
||
|
|
|
||
|
|
|
||
|
|
By: |
/s/ Nicholas R. Simmons |
|
|
|
|
Nicholas R. Simmons |
|
|
|
|
General Counsel |
|
3